Everolimus Modulation of Anti-tumor T CD4 Immune Responses
Clinical trial NCT02837757 · TERMINATED
Trial details
- NCT number
- NCT02837757
- Sponsor
- Centre Hospitalier Universitaire de Besancon
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-01
- Primary completion
- 2019-12-18
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.